What Interpace Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 3 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,243,772 | 141,847,734 |
| Disposed | 581,718 | 581,718 |
| Net activity | +1,662,054 | +141,266,016 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Burnell Thomas W. | CEO, President & Chairman | Aug 20 | Withheld — tax / exercise cost · F | −581,718 | $1.61 | −$937K | 1,455,927 |
| Burnell Thomas W. | CEO, President & Chairman | Aug 20 | Exercise / conversion · M | +1,966,763 | — | — | 2,037,645 |
| McCarthy Christopher | CFO & COO | Aug 20 | Exercise / conversion · M | +277,009 | — | — | 323,800 |
| Ampersand 2018 Limited Partnership | 10% owner | Jan 20 | Derivative Conversion · C | +13,861,386 | $2.02 | +$28M | 13,861,386 |
| 1315 Capital II, L.p. | 10% owner | Jan 20 | Derivative Conversion · C | +9,405,941 | $2.02 | +$19M | 9,405,941 |
| McCarthy Christopher | Chief Financial Officer | Dec 01 | Exercise / conversion · M | +1,111 | — | — | 46,791 |
| McCarthy Christopher | Chief Financial Officer | Jul 27 | Exercise / conversion · M | +15,112 | — | — | 45,680 |
| McCarthy Christopher | Chief Financial Officer | Feb 01 | Grant / award · A | +10,000 | — | — | 45,644 |
| McCarthy Christopher | Chief Financial Officer | Feb 01 | Exercise / conversion · M | +6,045 | — | — | 30,568 |
| McCarthy Christopher | Chief Financial Officer | Jan 31 | Exercise / conversion · M | +7,556 | — | — | 24,523 |
| McCarthy Christopher | Chief Financial Officer | Dec 01 | Exercise / conversion · M | +1,095 | — | — | 16,967 |
| McCarthy Christopher | Chief Financial Officer | Jul 31 | Grant / award · A | +25,000 | — | — | 35,644 |
| McCarthy Christopher | Chief Financial Officer | Jul 31 | Exercise / conversion · M | +7,556 | — | — | 15,872 |
| Burnell Thomas W. | President & CEO | May 21 | Open-market buy · P | +10,855 | $8.68 | +$94.2K | 10,855 |
| Freeburg Thomas John | Chief Financial Officer | Mar 10 | Grant / award · A | +50,000 | — | — | 52,000 |
| Kamin Peter H | 10% owner | Mar 01 | Open-market buy · P | +2,862 | $3.08 | +$8.81K | 44,670 |
| Kamin Peter H | 10% owner | Mar 01 | Open-market buy · P | +8,252 | $3.08 | +$25.4K | 133,186 |
| Kamin Peter H | 10% owner | Mar 01 | Open-market buy · P | +14,726 | $3.08 | +$45.4K | 234,805 |
| Kamin Peter H | 10% owner | Mar 01 | Open-market buy · P | +16,360 | $3.08 | +$50.4K | 270,108 |
| Kamin Peter H | 10% owner | Feb 26 | Open-market buy · P | +2,897 | $3.17 | +$9.18K | 41,808 |
Loading...
